Startups
Rigshospitalet is Denmark’s most highly specialised hospital, providing treatment for people in Denmark, the Faeroe Islands and Greenland. We stand for an open and inclusive hospital with focus on patient needs. Also we focus on being an efficient workplace promoting wellbeing for our approximately 12.000 employees. Through our skilful employees we are among the best in Europe; professionally and for training and research. On 1 January 2015 Rigshospitalet merged with Glostrup Hospital, making it the largest hospital in Denmark.
Overview
Location
Denmark, Capital Region of Denmark, Copenhagen
Employees
10001+
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 12, 2026 | Cessatech enters collaboration with University Hospital of Copenhagen, Rigshospitalet, to advance an intravenous formulation of melatonin for post-anaesthesia delirium (CT004) in children | Cessatech enters collaboration with University Hospital of Copenhagen, Rigshospitalet, to advance an intravenous formulation of melatonin for post-anaesthesia delirium (CT004) in children Fri, Jun 12, 2026 13:30 CET Report this content CT00... |
| May 28, 2026 | Interim report Q1 2026 | Interim report Q1 2026 Thu, May 28, 2026 07:00 CET Report this content Copenhagen, Denmark, 28 May 2026 - Curasight A/S (TICKER: CURAS) a clinical-stage radiopharmaceutical company pioneering first-in-class uPAR-targeted radioligand platfor... |
| May 26, 2026 | New analysis shows Tryngolza® (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia | New analysis shows Tryngolza® (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia Tue, May 26, 2026 16:15 CET Report this content Sobi® (STO: SOBI) today announced results from a new analysi... |
| Mar 10, 2026 | Notice of Annual General Meeting 2026 | Notice of Annual General Meeting 2026 Tue, Mar 10, 2026 18:26 CET Report this content March 25, 2026 The Board of Directors is pleased to invite shareholders to the Annual General Meeting of Curasight A/S (“Curasight” or the “Company” – TIC... |
| Jan 12, 2026 | Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT[®] in High-Grade Gliomas | Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT[®] in High-Grade Gliomas Mon, Jan 12, 2026 18:00 CET Report this content Clear uptake of uTREAT® in aggressive brain ca... |
| Aug 5, 2025 | Successful Conclusion of Groundbreaking First-in-Human Trial for Revolutionary Non-Blood-Contacting reBEAT Heart Support Device, Clears Path for Transformative US study | MISSION-reBEAT Investigators from Hannover Medical School prepare to implant the reBEAT heart support device around a study patient's heart during this first-in-human trial. AdjuCor GmbH has successfully completed the world's Firs... |
| Jan 18, 2025 | Qlife's Leap into Home Diagnostics: A New Era of Health Monitoring | In the fast-paced world of healthcare, innovation is the lifeblood that keeps the industry thriving. Qlife, a rising star in the home diagnostics arena, is making waves with its Egoo Health platform. This platform is not just a product; it’... |
| Jan 14, 2025 | Qlife provides sales and regulatory updates | Qlife provides sales and regulatory updates Tue, Jan 14, 2025 09:00 CET Report this content The company has shifted its focus from research and development to becoming a sales-driven organization, emphasizing the distribution of its high-qu... |
| Oct 4, 2024 | Oxcia is focusing the development of OXC-101 on hematological cancers | Oxcia is focusing the development of OXC-101 on hematological cancers Fri, Oct 04, 2024 13:11 CET Report this content Following a strategy and data review, Oxcia has chosen to re-prioritize the clinical development of OXC-101 from solid tum... |
Show more
Reviews 0
FAQ about Rigshospitalet
What has the press written about Rigshospitalet?
Parsers VC has collected 11 articles mentioning Rigshospitalet, among them “Cessatech enters collaboration with University Hospital of Copenhagen, Rigshospitalet, to advance an intravenous formulation of melatonin for post-anaesthesi...” (Jun 12, 2026) and “Interim report Q1 2026” (May 28, 2026).
Is Rigshospitalet still active?
Rigshospitalet is probably closed: its latest activity on Parsers VC dates from Aug 28, 2026.